DCAP yields 0.08% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 4
Combined, DCAP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DCAP + JNJ for your $10,000?
DCAP takes two different approaches to investing in the US equity market, utilizing both passively managed broad-based ETFs and actively selecting individual stocks. The passive approach aims to maintain consistent diversification and foundation for the portfolio. Individual stocks are selected based on an assessment of competitive advantages, growth rates relative to peers, business models, and financial strength. The portfolio may tilt towards one approach over the other based on macroeconomic developments, valuation, and technical indicators. The funds options overly strategies aim to generate income which may include covered calls, put spreads, call spreads, and iron condors. All option strategies will be risk-defined using option spreads, with the maximum risk being the difference between the strike prices less the premium received.
Full DCAP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.